Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 1 , Pages 1-7, March 2008

Characterization of an antibody scFv that recognizes fibrillar insulin and β-amyloid using atomic force microscopy

  • Warren D. Marcus, PhD

      Affiliations

    • Department of Physics and Astronomy, Arizona State University, Tempe, Arizona
    • Department of Chemical and Materials Engineering, Arizona State University, Tempe, Arizona
    • Corresponding Author InformationCorresponding author: Altor Bioscience Corporation, 2810 N Commerce Parkway, Miramar, Florida 33025, USA.
    • No longer at Arizona State University but all work performed while there.
  • ,
  • Hongda Wang, PhD

      Affiliations

    • Department of Physics and Astronomy, Arizona State University, Tempe, Arizona
  • ,
  • Stuart M. Lindsay, PhD

      Affiliations

    • Department of Physics and Astronomy, Arizona State University, Tempe, Arizona
    • The Biodesign Institute at Arizona State University, Arizona State University, Tempe, Arizona, USA
  • ,
  • Michael R. Sierks, PhD

      Affiliations

    • Department of Chemical and Materials Engineering, Arizona State University, Tempe, Arizona

Received 18 April 2007; accepted 13 November 2007. published online 17 January 2008.

Abstract 

Fibrillar amyloid is the hallmark feature of many protein aggregation diseases, such as Alzheimer's and Parkinson's diseases. A monoclonal single-chain variable fragment (scFv) targeting insulin fibrils was isolated using phage display technology and an atomic force microscopy (AFM) mica substrate. Specific targeting of the scFv to insulin fibrils but not monomers or other small oligomeric forms, under similar conditions, was demonstrated both by enzyme-linked immunosorbent assays and AFM recognition imaging. The scFv also recognizes β-amyloid fibrils, a hallmark feature of Alzheimer's disease. The results suggest that the isolated scFv possibly targets a shared fibrillar motif—probably the cross-β-sheet characteristic of amyloid fibrils. The techniques outlined here provide additional tools to further study the process of fibril formation. The scFvs isolated can have potential use as diagnostic or therapeutic reagents for protein aggregation diseases.

Key words: Amyloid fibrils, Single-chain variable fragment, Atomic force microscopy, Phage display, Cross-β-sheet

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The National Institutes of Health is acknowledged for funding this research through the minority postdoctoral supplement award.

 W.D. Marcus, H. Wang, S.M. Lindsay, M.R. Sierks, Characterization of an antibody scFv that recognizes fibrillar insuling and B-amyloid using atomic force microscopy. Nanomedicine: NMB 2008; 4: 1-6, doi: 10.1016/j.nano.2007.11.003.

PII: S1549-9634(07)00248-1

doi:10.1016/j.nano.2007.11.003

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 1 , Pages 1-7, March 2008